Cardio-Respiratory Failure
8
1
1
4
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 25/100
0.0%
0 terminated out of 8 trials
100.0%
+13.5% vs benchmark
0%
0 trials in Phase 3/4
75%
3 of 4 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 4 completed trials
Clinical Trials (8)
Safety and Performance of the Novalung Ultimate Kit and Xenios 2.0 During Stationary Use in Hospital and Ground-based Transport of Patients on Extracorporeal Life Support (ECLS)
A Post Market Surveillance Study of the Hemovent Extracorporeal Cardiopulmonary Support System:The MOBYBOX Trial
Motivational Program on Physical Activity in Cardio-respiratory Patients: an RCT Study
Optimizing a Mobile Mindfulness Intervention for ICU Survivors
Lift Mobile Mindfulness for COVID-19 Distress Symptoms
Mobile Coping Skills Training to Improve Cardiorespiratory Failure Survivors' Psychological Distress
Evaluation of Modification in VO2 Max After Performing the "Physical Activity and Health Course (PAPS) 53" Program
Harnessing Alternative Resources to Aid Kenyans With Acute Illness